FBR Capital Reiterates Outperform on Galena Biopharma (GALE) Following Phase lll Investigation
Go back to FBR Capital Reiterates Outperform on Galena Biopharma (GALE) Following Phase lll Investigation| GALENA BIOPHARMA (NASDAQ: GALE) | Delayed: 0.21 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.21 | 52 Week High | $4.00 | |||
| Open | $53.00 | 52 Week Low | $0.16 | |||
| Day High | $0.21 | P/E | N/A | |||
| Day Low | $0.21 | EPS | $-0.37 | |||
| Volume | 12,025 | |||||
